Professional Documents
Culture Documents
IM Vascular Diseases of The Extremities (2018)
IM Vascular Diseases of The Extremities (2018)
INTERNAL MEDICINE II
FACILITATOR: Jonah L. Amora, MD, FPCP, FPCC DATE: December 12, 2016
OUTLINE
• The most common disease entity that can affect our PATHOLOGY
extremities and vasculature is Peripheral Artery Disease.
• Stenosis or occlusion in the aorta or arteries of the limbs
• Number 1 cause in individuals 40 and above:
ATHEROSCLEROSIS
§ 2016: It is a lifelong process but for people with risk factors,
atherosclerosis may progress faster and more advance even if
they are younger
§ Other causes include embolism, thrombosis,
vasculitis, trauma
• Highest prevalence occurs in 60 and 70+ because
atherosclerosis is a lifelong process
• Risk factors – The risk factors for PAD are the same as those
for CAD
§ SMOKING
§ DIABETES MELLITUS
§ HYPERCHOLESTEROLEMIA
§ HYPERTENSION
§ HYPERHOMOCYSTEINEMIA
§ 2016: This risk factors contributes to accelerate the process of On the atherosclerotic artery (right), a plaque has been formed which
atherosclerosis which may increase the chance to develop PAD leads to stenosis. There is a decreased blood flow but there is no
§ 2016: The first four are the most important and are the MAJOR presence of total occlusion. Take note that there is a difference
RISK FACTORS between saying that “may baradong ugat” and “may masikip na
ugat”. Masikip na ugat means that there is just stenosis but there is
RISK FACTORS still blood flow. Baradong ugat means that there is total occlusion.
They are two different things and they have different implications for
• 2-4x increase in prevalence of PAD in CURRENT SMOKERS the patient. So again just take note that atherosclerosis can lead to
compared to never smokers decreased blood flow because of the stenosis.
• DIABETES MELLITUS patients have 2-4x increased risk and
often have extensive and severe PAD • Segmental lesions in large and medium-sized vessels
§ 2016: greater propensity for arterial calcification • 2016: Scenario: Patient goes to emergency room with chest pain.
• HYPERCHOLESTEROLEMIA: Increase in total and LDL Would you consider CAD as most likely cause of chest pain for the
cholesterol increases risk for PAD and claudication patient?
• HYPERTENSION increases risk for PAD by 1.3 to 2.2 § Base on the concept of risk factors for advance atherosclerosis,
it would be the LEAST consideration for the chest pain in
§ 2016: People who smoke has a greater risk than
individuals around 23-32 years old
hypertension people in developing atherosclerosis § BUT if patient is 60 above, smoker, non-compliant with
• The magic number here is “2”. Almost all the risk factors give a hypertensive meds, you have a 90% of being right that this
twofold increase in developing PAD. is PAD
Conventional Angiography
An example of an angiographic view demonstrating the iliacs and its
major branches. You can see some narrowing here, but it’s not really
that significant.
Sample picture of segmental pressure measurements with
PROGNOSIS
corresponding waveforms.
• CAD commonly coexists in symptomatic PAD
§ If the vessels in the extremities are already affected,
then most likely the coronary vessels are also affected
because they have smaller calibers.
§ 33% to 50% of PAD have evidence of CAD, based on
symptoms and ECG
w 2016: PAD patients die more of cardiovascular
events rather than PAD, due to same
pathophysiology (atherosclerosis)
§ > 50% have significant CAD based on coronary
angiogram
• 2-6x increased risk of death from CAD
§ Prognosis of these patients is greatly influenced by the
presence of CAD
Segmental Pressure and PVRs
§ CAD is the most common cause of death in PAD, with
up to 6x increased risk of death due to CAD.
§ If a patient presents with leg pain and you diagnose
him/her PAD, you should automatically work him/her up
for CAD.
• Severe PAD: highest mortality rates
§ Severe PAD: those with gangrene, ulcers, critical limb
ischemia
§ Be more aggressive with treatment
FIBROMUSCULAR DYSPLASIA
THROMBOANGIITIS OBLITERANS
• AN ACUTE EVENT! Much like an acute MI. w Common femoral, deep femoral, superficial
• Sudden cessation of blood flow to an extremity femoral – the femoral artery has several
• Two principal causes/soruces: bifurcations kaya dito siya nagbabara.
§ EMBOLISM and
§ THROMBUS IN SITU ARTERIAL THROMBUS (IN SITU )
• Atherosclerotic vessels
ARTERIAL EMBOLISM o The cap of an unstable plaque might be peeled off
• Most common sources of arterial emboli are the (1) heart, (2) and it will work like an acute MI.
aorta, and (3) large arteries o The ruptured plaque leads to the formation of a clot
• Cardiac sources: Atrial Fibrillation (AF), Acute myocardial • Bypass grafts
infarction (AMI), cardiomyopathy (CMP), aneurysm,
endocarditis, myxoma, prosthetic valves
§ 2016: If you have any of these, then the high chance that you 2016: In patients with any occlusion, there are only 2 causes. You
could develop an event due to embolism. have to do your history and PE, to detect whether it is an embolism or
• Emboli commonly lodges in your bifurcations/branches. thrombus in situ.
§ Most common location on lower extremities for
arterial embolism: femorals
2016:
• These patients do not have atrial contraction.
• Remember the cardiac cycle?
§ EARLY diastole: rapid inflow of blood from the atrium to the ventricle, because of
momentum.
§ LATE diastole: – Atrial contraction. This contributes to about 30% of the cardiac
output.
• So in patients with atrial fibrillation, they lose about 30% of the CO.
• But the problem with patients with atrial fibrillation that predispose them to embolism is that
they have a dilated left atrium.
• Since they do not have atrial contraction, and they have a dilated left atrium, these patients
are predisposed to blood clot or thrombus formation due to STASIS inside the left and the
right atrium.
• Once there is a blood clot in the left atrium, it can be dislodged and will move into the left
ventricle and into the systemic circulation.
§ Patients with AF have a common complication of cerebral vascular infarct because of the
emboli lodge in the cerebral arteries.
• Common complication: HYPOTENSION
§ Because atrial fibrillation commonly appears with rapid ventricular response – a fast
heart rate will compromise the diastolic filling of blood plus the lost of 30% of CO due to
absence of atrial contraction.
ACUTE • The heart is enlarged and dilated, there could be an aneurysm.
MYOCARDIAL • A blood clot can form in the aneurysm because of stasis and this clot can then once again
INFARCTION embolize to other areas.
2016:
• A portion of the left ventricle dies.
• A heart is basically a pump. When 40% of the left ventricle dies and only 60% is left, so the
portion with MI is actually dead, so there is stasis of blood.
2016:
• Vegetation
§ One of the criteria in the diagnosis of endocarditis.
§ Once it is dislodged from one of the valves that affected it can move into any artery and
cause infarct of the brain and can even cause MI (unusual)
MYXOMA 2016:
• A big tumor that if dislodged, can cause fatal infarction
• Most common location: LEFT ATRIUM.
PROSTHETIC • Can be a nidus for clot formation leading to embolism.
VALVES
2016:
• Because it is a foreign body in the heart, it can predispose to thrombus or blood clot formation.
§ Patients taking warfarin or coumadin should monitor their Protime monthly to
decrease embolism.
SYMPTOMS OF AAO • Image: Necrosis involving the two digits. There is also
• Severe pain, paresthesia, numbness, coldness of extremities hypoperfusion (decrease of blood flow) since the color of some
§ 5Ps: Pain, paresthesia, pallor, poikilothermia, digits is pale.
pulselessness • Sometimes they would remove the fingers and preserve the big
• Paralysis may occur with severe and persistent ischemia toe to minimize the disability of the patient.
• Loss of pulses, cyanosis, mottling, decreased skin
temperature, muscle stiffening, weakness TREATMENT FOR ACUTE ARTERIAL OCLUSSION
§ Common symptoms on patients with arterial
hypoperfusion • Anticoagulation with INTRAVENOUS HEPARIN to prevent
§ We do not see the secondary skin changes in AAO propagation of the clot.
because this is an acute event. § 2016: Heparin is an anticoagulant so the purpose is
• Diagnosis usually obvious from clinical presentation prevent the formation of further clots and prevent
• Most patients will require: propagation of clot. Wag ng lumaki at wag ng
§ MRA (Magnetic Resonance Angiogram), madagdagan.
§ CTA (Computerized Tomography Angiogram), • IMMEDIATE ENDOVASCULAR / SURGICAL
§ Conventional arteriography THROMBOEMBOLECTOMY OR ARTERIAL BYPASS
§ The diagnostic tools to fully investigate the location and • INTRA-ARTERIAL THROMBOLYSIS
extent of obstruction. § with recombinant tissue plasminogen activator (rTPA),
reteplase, tenecteplase
§ Effective when occlusion due to thrombus in bypass
graft or atherosclerotic vessel
§ You can inject all of these in order to save the limb.
§ 2016: Same pathophysiology with coronary artery disease,
treatment is also related or the same in a way: the idea is to
lyse the thrombus causing the acute arterial occlusion
§ 2016: If you are talking about acute arterial occlusion then a
role of a thrombolytic drug is more appropriate. Sudden, and if
you have a chance in saving the extremities, you should
dissolve that clot or thrombus as early as possible.
§ 2016: And if that medical treatment is not successful, you can
do other intervention like catheter-based interventions.
• AMPUTATION when limb is not viable
§ You do the first 3 only when the limb is still viable. If it is
not viable, then you would have to amputate the limb
• The end effect of ARTERIAL OCLUSSION whether it is ACUTE
already.
or CHRONIC would be NECROSIS or GANGRENE of a portion
of the extremity.
6 | DLSHSI COLLEGE OF MEDICINE Batch 2018
RAYNAUD’S PHENOMENON
TREATMENT
• “Episodic sequential digital ischemia” • Avoid unnecessary cold exposure
• Episodic digital ischemia, manifested by sequential • Avoid tobacco use
development of § What disease is treated only by cessation of smoking????
§ Digital blanching
BUERGER’S DISEASE! Correct!
w Vasospasm of digital arteries, causing ischemia
• Calcium channel blockers in severe cases
§ Cyanosis
w Capillaries and venules dilate • Alpha-1 adrenergic antagonists: prazosin
§ Rubor of fingers or toes • Topical nitrates
w Rewarming, reactive hyperemia § For frequently symptomatic or severe cases
#THROWBACK:
Remember Pathology? Dr. Pascual’s mnemonic for the sequence in 2016 NOTES
Raynaud’s Phenomenon: WeBeR -> white, blue, red. It even came out in • In patient who are persistently asymptomatic: CALCIUM
our Evals back then! Okay. Enough reminiscing, back to work... CHANNEL BLOCKERS in severe cases.
§ Calcium channel blockers are indicted since it is use for
§ This phenomenon usually occurs after cold exposure VASODILATOR of the ARTERIES
and subsequent rewarming. w Prevent the spasm and cause dilation of the
w 2016: The postulated mechanism is the SPASM of smooth muscles in the arteries located in the
the arteries. tunica media, and
w Prevents the entry of calcium for muscle
RAYNAUD’S DISEASE contraction.
• When secondary causes of Raynaud’s phenomenon are § 2016: Why would Calcium-channel blockers be used?
What are the most common indication of the use of
excluded
calcium-channel blockers? HYPERTENSION. And the
§ DO NOT BE CONFUSED. Raynaud’s disease is the
reason we use these for hypertension is because it dilate
idiopathic form (an actual disease) – diagnosed when
the arteries
you have ruled out all other secondary causes. § Examples: 1st gen CCB - Nifedipine, Verapamil,
§ Raynaud’s phenomenon is a sign that can be seen in Diltiazem
several other diseases w The problem with Nifedipine is it is short acting so
• Female preponderance, 20-40 y/o you have to give it every 6 or every 8 hours.
• FINGERS more involved than toes § 2016: CCB drugs that are most commonly used in
treatment of hypertension: Amplodipine, Phyllodipine,
SECONDARY CAUSES (of Raynaud’s Phenomenon) Nacidiphine
§ 2016: These are long acting vasodilator CCBs, you give it
• Systemic sclerosis
once a day and usually it is enough to control the
§ Up to 90% of patients with Sscle have Raynaud’s
hypertension.
Phenomenon
• SLE
§ Up to 20% of patients with SLE have Raynaud’s
Phenomenon
• Atherosclerosis: men >50 y/o
• Thromboangiitis obliterans (Buerger’s Disease)
• Blood dyscrasias
• Drugs: beta-blockers, ergot derivatives, vinblastine, cisplatin,
bleomycin
• Raynaud’s phenomenon. Blanching and cyanosis
• It is something that is paroxysmal / episodic. But for patients
with short periods of Raynaud’s phenomenon, you do not need
to treat them only those patients with severe.
VENOUS THROMBOSIS & SUPERFICIAL VEIN THROMBOSIS
2016 NOTES
if PERIPHERAL ARTERY DISEASE: temp-COLD and ↓PULSE
if SUPERFICIAL VEIN THROMBOSIS: red, warm and tender cord
VARICOSE VEINS
CLINICAL FINDINGS
• Dull ache or pressure sensation after prolonged standing
• Extensive varicosities may cause skin ulcerations near the
ankle
• Mild ankle edema TREATMENT
• May rarely rupture and bleed • Supportive
• Patients usually complain of the cosmetic appearance. “Hala, § Leg elevation, elastic support hose
hindi na flawless” L § External compression stockings
w These stockings have particular sizes and
pressures. You don’t just use whatever stockings
you want.
• Sclerotherapy
§ Injecting of sclerosing solution
• Radiofrequency or laser ablation
• Surgery
§ Ligation and vein stripping
HYPOTHYROIDISM
• Reduced cardiac output, stroke volume, heart rate, blood pressure, and pulse pressure.
• Pericardial effusion in 1/3 of patients even pleural effusions
§ They retain a lot of fluids
§ In patients who have hypercholesterolemia and apparently not responding to the
treatment (statin), then check for the thyroid function test because hypothyroidism
present also with elevated cholesterol and triglycerides.
§ Patients with hypothyroidism need to undergo echocardiogram for documentation,
because 33% have pericardial effusion
• ECG: sinus bradycardia, low voltage, QT prolongations, conduction disturbances
• Elevated cholesterol and triglycerides